BTL

What BTL does

BTL Industries is a privately held global medical technology company founded in 1993 and headquartered in Prague, Czech Republic, that designs, manufactures, and sells proprietary medical and aesthetic devices across three segments: medical aesthetics, rehabilitation/orthopedics, and cardiology/cardiovascular diagnostics. Its product portfolio spans 25+ named devices including EMSCULPT NEO and EMFACE (body and facial aesthetics using RF combined with HIFEM/HIFES), EMSELLA (pelvic floor), EXOMIND (FDA-cleared non-invasive brain stimulation for mental health), BTL Robotics (Exo, R-Gait, R-Force, R-Touch, R-Lead, BTL Walk for neurorehabilitation), physiotherapy devices (Focused/Radial Shockwave, High Intensity Laser, Super Inductive System, Spinal Decompression, Cryotherapy), and a cardiology line (BTL 4 ECG, BTL 8 ECG, BTL Flexi ECG — all AI-assisted — plus Holter, ABPM, Stress Test, CPET, Spirometry) unified under the BTL CardioPoint software platform and integrated with hospital information systems via HL7/DICOM.

The company makes money primarily through direct enterprise field sales of capital medical hardware, supplemented by post-sale service, training, and clinical education programs. Pricing is quote-based and not publicly disclosed. Go-to-market is field-sales-led across direct branches in 80+ countries on six continents, with authorized distributors filling non-direct markets. Customers span cardiology practices, physiotherapy and rehabilitation centers, medical aesthetic clinics, public and private hospitals, and professional sports organizations — a portfolio that diversifies cyclical exposure across elective aesthetics, structural rehabilitation demand, and non-discretionary diagnostics. CEO Tomas Schwarz leads an organization that retains in-house R&D, manufacturing, and a global service network; available data indicates 101-250 employees and a privately held ownership structure with no disclosed institutional investors.

Notable recent strategic activity includes successful global patent enforcement against a competing facial aesthetics device (EMFACE), launch of three new AI-powered ECG devices in 2025, expansion into mental health via EXOMIND in 2026, a high-visibility partnership with the Dallas Cowboys for athlete recovery applications, and use of EMSCULPT NEO in astronaut training for an International Space Station mission — collectively indicating both offensive product/segment expansion and defensive IP protection.

Name

BTL

Legal name

BTL Industries

Website

https://btl.ro

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

BTL Industries is a privately held global medical technology company, founded 1993 in Prague, that designs and manufactures proprietary medical devices across aesthetics (EMSCULPT NEO, EMFACE, EMSELLA, EXOMIND), rehabilitation/robotics, and cardiology diagnostics, sold via direct sales in 80+ countries.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industry

Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL)

Keywords

• Medical device manufacturing
• Cardiology diagnostic equipment
• Physiotherapy rehabilitation systems
• Medical aesthetic devices
• Robotic neurorehabilitation

Headquarters

HQ city

Bucurestii Noi

HQ country

Romania

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of medical and aesthetic equipment including physiotherapy devices, cardiology systems, and aesthetic treatment devices to healthcare facilities globally
2. Service and Support: Post-sale technical support, training, and maintenance services provided through trained service engineers at branches and distributors worldwide
3. Clinical Education: Educational programs, webinars, and training sessions for healthcare professionals on BTL device operation and clinical applications

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

BTL designs, manufactures, and globally distributes proprietary medical devices across three core segments: cardiology/cardiovascular diagnostics (ECG, stress test, Holter, ABPM, CPET, spirometry, and the BTL CardioPoint software platform), physiotherapy and rehabilitation (focused and radial shockwave, high-intensity laser, Super Inductive System, TR-Therapy, spinal decompression, cryotherapy, ultrasound, electrotherapy, magnetotherapy, and BTL ROBOTICS for neurorehabilitation), and medical aesthetics (EMSCULPT NEO for body contouring, EMFACE for facial treatment, EMSELLA for pelvic floor health, and EXOMIND for non-invasive brain stimulation). Devices are sold to hospitals, clinics, and medical practices through direct sales branches in 80+ countries and authorized distributors, supported by training and post-sale service.

Product overview

BTL is a global medical technology company headquartered in Prague, Czech Republic, operating as one of the world's leading manufacturers of medical and aesthetic equipment with direct branches in over 80 countries. The company operates across three main segments: Medical Aesthetics, Rehabilitation and Orthopedics, and Cardiovascular and Pulmonary Solutions. The Medical Aesthetics portfolio includes EMFACE (facial treatment), EMSCULPT NEO (body contouring), EMSELLA (pelvic floor health), and EXOMIND (non-invasive brain stimulation for mental health). The Rehabilitation segment offers advanced technologies including Focused and Radial Shockwave, High Intensity Laser, Super Inductive System (including DUO variant), TR-Therapy, Spinal Decompression, and Cryotherapy, complemented by a robotic solutions line featuring BTL Exo, R-Gait, R-Force, R-Touch, R-Lead, and BTL Walk for neurorehabilitation. The Cardiovascular portfolio centers on the BTL CardioPoint unified software platform integrating all diagnostic modalities, supported by hardware including BTL 8 ECG (world's fastest), BTL 4 ECG (first AI-powered), BTL Flexi ECG (portable with AI), BTL Holter ECG, BTL ABPM, BTL Stress Test, BTL CPET, and BTL Spirometry. The company also offers BTL CONNECTin as a comprehensive hospital information system.

Differentiator

Problem solved

Functional benefit

Brands

• BTL CardioPoint: Integrated software platform for cardiovascular diagnostic data management covering ECG, stress test, Holter, ABPM, and spirometry.

Products and services

• BTL 8 ECG Professional-grade electrocardiograph for large medical facilities with high patient volumes, featuring AI-powered ECG analysis, contactless RFID authentication for patient identification, continuous long-term operation, and HL7/DICOM connectivity.
• BTL 4 ECG First AI-powered ECG device with integrated AI algorithm for ECG interpretation, electrode positioning guide, vacuum electrode option, and reduced operational costs by up to 74%.
• BTL Flexi ECG Ultra-compact portable ECG system for daily clinical practice with AI-powered ECG interpretation, SDS module for sudden cardiac death screening, ST Maps, QT Maps, wireless Wi-Fi connectivity, and three working modes for flexible deployment.
• BTL Holter ECG Ambulatory ECG monitoring system providing maximum signal quality in demanding conditions, certified for pediatric patients weighing under 10 kg, and integrated into the BTL CardioPoint platform for comprehensive cardiac diagnostics.
• BTL ABPM Ambulatory blood pressure monitoring device with compact design, silent operation, recording up to 51 hours, step-deflation technology, and BHS, AAMI, and IEC validation. Includes three cuff sizes and automated evaluation.
• BTL Stress Test Advanced stress test system with simple operation and automated functions enabling physicians to extract maximum information from exercise testing, available in wired and wireless (BTL Flexi) configurations.
• BTL CPET Cardiopulmonary exercise testing system with CO2 sensor calibration, moveable sensor-free flowmeter, simultaneous cardiac and pulmonary data display, and QT/QTc monitoring.
• BTL Spirometry Professional spirometry solution with reusable sensors and mouthpieces, supporting FVC, SVC, MVV maneuvers, automated child stimulation, pre/post bronchoprovocation testing, and automated interpretation per ATS/ERS standards.
• BTL CardioPoint Unified software platform integrating all BTL cardiovascular diagnostic examinations including resting ECG, stress test, Holter ECG, ambulatory blood pressure monitoring, and spirometry into a single system for streamlined cardiology workflow management.
• BTL Exo Exoskeleton-based robotic rehabilitation system for neurorehabilitation, providing gait training and mobility assistance for patients with neurological conditions.
• R-Gait End-effector type robot-assisted gait training system for neurorehabilitation, clinically proven to improve step count by ~48%, walking distance by ~63%, and gait speed by ~39% in pediatric neurological patients.
• R-Force Body-weight supported treadmill training system for gait rehabilitation, used in clinical studies demonstrating improvement in gait symmetry in patients after orthopedic surgeries.
• R-Touch Robotic hand therapy system for neurorehabilitation providing upper extremity rehabilitation through automated therapeutic movements.
• R-Lead Robotic therapy system for lead rehabilitation, supporting neurorecovery programs.
• BTL Walk Walk assistance robot for mobility support, part of the BTL robotics portfolio for rehabilitation applications.
• Focused Shockwave Focused shockwave therapy system for orthopedics and rehabilitation, delivering targeted acoustic waves to stimulate healing in bone and soft tissue conditions.
• Radial Shockwave Radial shockwave therapy device for treating musculoskeletal conditions by applying acoustic waves over a broader area, commonly used for tendinopathies and plantar fasciitis.
• High Intensity Laser High-intensity laser therapy device for rehabilitation and pain management offering biostimulatory effects on nerve cell growth and repair, clinically proven effective for motor deficit improvement in lumbar disc hernia patients.
• Super Inductive System Advanced electromagnetic therapy system for pain management, muscle stimulation, and joint mobilization in rehabilitation and orthopedic applications.
• Super Inductive System DUO Advanced version of the Super Inductive System technology offering enhanced capabilities for rehabilitation and orthopedics applications.
• TR-Therapy Targeted Release therapy system for deep tissue treatment and pain relief through combined vacuum and electrical stimulation.
• Spinal Decompression Non-surgical spinal decompression therapy system for treating disc-related back pain and promoting spinal rehabilitation.
• Cryotherapy Cold-air cryotherapy device for tissue cooling in musculoskeletal injuries, clinically proven to achieve 15.85 degrees C temperature reduction immediately after treatment.
• EMSCULPT NEO Body contouring device combining radiofrequency heating with HIFEM energy to stimulate supramaximal muscle contractions for fat reduction and muscle toning, also used in athlete recovery and astronaut training applications.
• EMFACE Facial treatment device combining synchronized RF and HIFES technologies for simultaneous skin tightening and facial muscle stimulation, subject of successful BTL patent enforcement.
• EMSELLA Non-invasive chair device for urinary incontinence treatment and pelvic floor health using high-intensity focused electromagnetic technology to stimulate pelvic floor muscles.
• EXOMIND FDA-cleared non-invasive brain stimulation technology using magnetic pulses to treat symptoms of depression and support mental health, emotional regulation, and cognitive performance.
• BTL CONNECTin Comprehensive hospital information system that digitizes hospital operations, optimizes workflows, eliminates paper documentation, and provides secure access to patient records, supporting efficient and modern medical practice.

Quantifiable outcome

• BTL's EMSCULPT NEO demonstrated significant improvements in muscle performance and recovery during astronaut training for ISS mission
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature12 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• Dallas CowboysflagshipStrategic or Co-development Partner · 2 June 2026BTL, a global leader in advanced medical technologies, announced a collaboration with the Dallas Cowboys to incorporate EMSCULPT NEO® into the team's athlete recovery and conditioning program. The technology uses radiofrequency heating combined with HIFEM® energy to stimulate powerful supramaximal muscle contractions for player rehabilitation, strength, and performance. Both organizations indicated plans to expand the collaboration to further enhance player recovery and optimize long-term athlete health.
• Asociația Medici pentru RomâniacoreStrategic or Co-development Partner · 5 February 2026BTL România partnered with Asociația Medici pentru România in the renovation project of the Pediatrics Department at Spitalul Municipal Curtea de Argeș. The total investment exceeded 1,000,000 euros, realized exclusively through sponsorships and donations. The renovated department serves over 5,000 children annually from Curtea de Argeș and neighboring localities.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• InMode: Medical-aesthetic platform with RF, IPL, and body-contouring technologies competing head-to-head with BTL's EMFACE and EMSCULPT NEO across plastic-surgery and aesthetic-practice channels.
• Cynosure: Aesthetic energy-device manufacturer offering laser, RF, and body-contouring systems that compete directly with BTL's EMSCULPT NEO and EMFACE in medical spas and aesthetic clinics. Serves the same non-invasive treatment market BTL leads.
• Cutera: Aesthetic device company selling laser, RF, and body-contouring platforms (e.g., truSculpt) that overlap directly with BTL's aesthetic portfolio targeting dermatologists and medical spas.
• Hocoma (DIH): Robotic rehabilitation specialist behind Lokomat and Armeo — a direct competitor to BTL's R-Gait, R-Force, and BTL Exo in neurological gait and upper-limb neurorehabilitation.
• Allergan Aesthetics (AbbVie): Owner of CoolSculpting, the most established non-invasive body-contouring brand and the primary commercial competitor to EMSCULPT NEO. Competes for the same clinic budgets and patient demand.
• Ekso Bionics: Exoskeleton developer for stroke and spinal-cord-injury rehabilitation, competing with BTL's BTL Exo and BTL Walk in the clinical exoskeleton segment.
• DJO / Enovis (Chattanooga): Broad rehabilitation and orthopedic equipment portfolio including shockwave, electrotherapy, and bracing — overlapping with BTL's physiotherapy product line sold to PT clinics and hospitals.
• Solta Medical (Bausch Health): Aesthetic device maker behind Thermage, CoolSculpting precursors, and Fraxel — a long-standing competitor in non-invasive skin tightening and body contouring adjacent to BTL's aesthetics franchise.

Broad incumbents

• Philips Healthcare: Large-scale provider of cardiology diagnostic equipment and patient-monitoring infrastructure; competes broadly in the same hospital ECG and cardiology workflow categories as BTL CardioPoint.
• GE HealthCare: Global cardiology diagnostics incumbent selling ECG, stress-test, Holter, and PACS platforms into hospitals. Broad incumbent rather than direct competitor, but the dominant installed base BTL's new AI-ECG line must displace.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/btl-ro
• Facebookfacebook.com/BTLRomaniaAparaturaMedicala

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BTL